Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Tuesday, February 10, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for February 2, 2015 through February 6, 2015

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Administration for Health Care Research and Quality (AHRQ)

·         Centers for Disease Control and Prevention (CDC)

·         Health Resources and Services Administration (HRSA)

·         Office of the Assistant Secretary for Health (OASH)

·         Office of the National Coordinator for Health IT (ONC)

·         Patient-Centered Outcomes Research Institute (PCORI)

·         National Institutes of Health (NIH)

 

 

NON-NIH Funding Opportunity Announcements:

 

AHRQ: Patient Safety Learning Laboratories: Innovative Design and Development to Improve Healthcare Delivery Systems

Funding Opportunity Number: RFA-HS-15-001

AHRQ funds research leading to patient safety improvements in all settings and systems of care delivery. To date, there has been a scarcity of programmatic activity that actually engages in new design and systems engineering efforts that is focused on more than singular patient safety concerns. This Funding Opportunity Announcement (FOA) calls for the creation and utilization of Patient Safety Learning Laboratories. These Learning Laboratories are places and professional networks where closely related threats to patient safety can be identified, where multidisciplinary teams generate new ways of thinking with respect to the threats, and where environments are established conducive to brainstorming and rapid prototyping techniques that stimulate further thinking. Learning Laboratories further enable multiple develop-test-revise iterations of promising design features and subsystems of the sort that can be found in larger-scale engineering projects. Once the closely aligned projects or subsystems are developed, integrated, and implemented as an overall working system, the ultimate function of the learning laboratory is to evaluate the system in a realistic simulated or clinical setting with its full complement of facility design, equipment, people (patients, family members, and providers), new procedures and workflow, and organizational contextual features, as appropriate. Applicants will select two to four closely related projects that focus on well-known, costly, patient safety harms in a given clinical area, and for which new and innovative design approaches are needed. While applicants will select the area of patient safety focus they consider of high significance, a flexible methodology problem analysis, design, development, implementation, and evaluation is provided that parallels the system development process to give an underlying structure to the four-year level of effort. This funding opportunity was announced on February 5, 2015. The application deadline is April 27, 2015. For more information, please visit AHRQ's Full Funding Opportunity Announcement.

 

CDC: Development and validation of laboratory procedures using next generation sequencing technologies to assess genes causing severe combined immune deficiency (SCID) in state newborn screening laboratories

Funding Opportunity Number: RFA-EH-15-002

This Funding Opportunity Announcement (FOA) is to develop, improve, and implement laboratory techniques to assess babies born with severe combined immune deficiency (SCID) and other primary immunodeficiencies using next generation sequencing technologies as a second tier test in state newborn screening laboratories. CDC seeks to evaluate the potential of using next generation sequencing technologies in the state newborn screening laboratory setting. Results of this activity will be used to inform other state newborn screening laboratories about the feasibility of using next generation sequencing technologies in the state newborn screening laboratory setting to evaluate babies that screen positive for SCID and other primary immunodeficiencies. The ultimate goal is to improve treatment outcomes for babies with SCID or other primary immunodeficiencies. This funding opportunity was announced on February 4, 2015. The application deadline is April 6, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

HRSA: Use of Social Media to Improve Engagement, Retention, and Health Outcomes along the HIV Care Continuum - Evaluation and Technical Assistance Center

Funding Opportunity Number: HRSA-15-031

This Funding Opportunity Announcement (FOA) solicits applications for an Evaluation and Technical Assistance Center for the Use of Social Media to Improve Engagement, Retention, and Health Outcomes along the HIV Care Continuum.  The successful applicant will be funded to lead a multi-site evaluation and provide technical assistance to a cohort of up to ten demonstration sites funded under a separate announcement (see FOA HRSA-15-029 to learn more about the demonstration sites).  Demonstration sites will implement, evaluate and disseminate findings from innovative methods of identifying, linking, retaining and improving health outcomes for HIV positive underserved, underinsured, and hard-to-reach youth and young adults through the use of social media. In particular, proposed methods must address ways to increase access to and retention in care for youth and young adults with poor utilization of health care or who are HIV infected but are unaware of their HIV status.  Demonstration sites will implement interventions based on innovative social media platforms to bring youth and young adults into health care at the early stages of HIV disease. This funding opportunity was announced on February 3, 2015. The application deadline is April 3, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: HIV Early Intervention Services Program Existing Geographic Service Areas 

Funding Opportunity Number: HRSA-15-135

This Funding Opportunity Announcement (FOA) solicits new and competing continuation applications for Ryan White HIV/AIDS Program (RWHAP) Part C Early Intervention Services (EIS). Funds will support outpatient HIV primary care services targeted to low-income, vulnerable, medically underserved people living with HIV/AIDS including women, infants, children and youth. The purpose of the RWHAP Part C EIS Program is to provide HIV primary care in the outpatient setting. Applicants must propose to provide a comprehensive continuum of outpatient HIV primary care services in the designated service area including (1) targeted HIV counseling, testing, and referral, (2) medical evaluation and clinical care (3) other primary care services, and (4) referrals to other health services. Primary care for persons with HIV disease should start as early in the course of the infection as possible; however, entry into a RWHAP Part C EIS program may take place at any point in the spectrum of the disease or the patient's lifespan. Applicants are expected to focus RWHAP Part C supported services on those populations of persons living with HIV (PLWH) who are the hardest to reach, have the greatest unmet need, and/or the greatest gaps in HIV primary care services as documented by local epidemiologic and needs assessment data.  These populations include (but are not limited to) minorities, youth, women, pregnant women, post-incarcerated persons, and homeless persons. This funding opportunity was announced on February 4, 2015. The application deadline is March 23, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: Medicare Rural Hospital Flexibility Grant Program

Funding Opportunity Number: HRSA-15-038

This Funding Opportunity Announcement (FOA) solicits applications for the Medicare Rural Hospital Flexibility Grant (Flex) Program.  The purposes of the Flex Program are to (1) provide support for critical access hospitals for quality improvement, quality reporting, performance improvements, and benchmarking; (2) designate facilities as critical access hospitals; and (3) provide rural emergency medical services. Through these activities the Flex Program ensure residents in rural communities have access to high quality health care services. The overall goals of the Flex program are to (1) improve the quality of care provided by CAHs, (2) improve the financial and operational outcomes of CAHs, (3) understand the Community Health and EMS Needs of CAHs, (4) enhance the health of rural communities through community/population health improvement, (5) improve identification and management of Time Critical Diagnoses and engage EMS capacity and performance in Rural Communities, and (6) support the financial and operational transition to value based models and health care transformation models in the health care system.  States will use Flex resources to address identified needs for CAHs within the state and to achieve improved and measurable outcomes in each selected program area. In order to maximize Flex funding, grantees are encouraged to look at funding cohorts of CAHs with similar challenges. While working on program activities, states are encouraged to work with state hospital associations, as well as quality improvement organizations (QIOs), quality innovation networks (QINs), health information exchanges (HIEs), hospital engagement networks (HENs), state rural health associations, and others concerned with the future of rural health care. This funding opportunity was announced on February 4, 2015. The application deadline is April 6, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: Rural Health Care Coordination Network Partnership Program

Funding Opportunity Number: HRSA-15-123

This Funding Opportunity Announcement (FOA) solicits applications for the Rural Health Care Coordination Network Partnership Program (Care Coordination Program). The purpose of the Care Coordination Program is to support the development of formal, mature rural health networks that focus on care coordination activities for the following chronic conditions: (1) diabetes, (2) congestive heart failure (CHF), and (3) chronic obstructive pulmonary disease (COPD).  Care coordination in the primary care practice involves deliberately organizing patient care activities and sharing information among all of the participants concerned with a patient's care to achieve safer and more effective care.  The increasing prevalence of chronic diseases and the high cost of health care in the U.S. bring treatment of the "whole" person to the forefront, especially as there are often psychosocial (psychological and social) issues related to chronic diseases. Reviews and reports from the Agency for Healthcare Quality and Research (AHRQ) have shown a positive impact from integrating a team approach to care for a variety of disease conditions.  The main goal of the Care Coordination Program is to meet patients' needs and preferences in the delivery of high-quality, high-value health care. This means that the patient's needs and preferences are known ahead of time and communicated at the right time to the right people. Care coordination is identified by the Institute of Medicine as a key strategy that has the potential to improve the effectiveness, safety, and efficiency of the American health care system.  Well-designed, targeted care coordination that is delivered to the right people can improve outcomes for everyone:  patients, providers, and payers. Care coordination is especially important in the changing health care landscape where payments increasingly focus on value.  The ultimate goal of the program is to promote the delivery of coordinated care in the primary care setting. There are numerous developments in state health policy that support the adoption of care coordination models, including patient centered medical homes (PCMH), accountable care organizations (ACO), and enhanced health information technology (HIT) such as electronic health records (EHR) and telehealth capabilities.  Care coordination strategies can be tailored for a rural community's resources and challenges.  Strategies may include a special emphasis on: recruiting or training personnel to assume care coordination responsibilities or supporting other staff, such as, community health workers, in taking on this role; developing new or making creative use of existing resources, such as co-locating available behavioral and primary health care services; and addressing quality improvement through innovations like telehealth or system redesign using models such as, Six Sigma or the Lean Model, for example. This funding opportunity was announced on February 5, 2015. The application deadline is April 6, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: Rural Health Clinic Policy and Clinical Assessment Program

Funding Opportunity Number: HRSA-15-125

This Funding Opportunity Announcement (FOA) solicits applications for the Rural Health Clinic Policy and Clinical Assessment Program.  The purpose of this program is to identify key policy, regulatory and clinical challenges facing Rural Health Clinics (RHCs) and identify possible solutions, while also informing them and other rural stakeholders about key RHC issues, including regulatory and programmatic changes that affect care delivery in these locations. The awardee will identify gaps in knowledge among RHCs about issues such as regulatory and program compliance, billing and reimbursement, quality improvement, best practices, disease management, and care coordination, and will propose tools, resources, and strategies to address them.  RHCs are geographically dispersed, so the proposed tools and resources should be easily accessible, including, but not limited to, listservs, conference calls, and webinars. RHCs are primary care clinics that are certified by the Centers for Medicare and Medicaid Services (CMS) to provide care in rural underserved areas.  They receive reasonable cost-based Medicare and Medicaid reimbursement, subject to certain conditions.  RHCs must be staffed by physician assistants and/or nurse practitioners.  Currently, there are more than 4,000 RHCs located in 44 states.  The health care delivery system is undergoing dramatic change, with an emphasis on finding new approaches to improve health outcomes, control costs, and improve population health.  Financial incentives are moving from volume-based to value-based services, with a focus on quality of care in all settings and improving transitions of care as patients move between care settings.  Within this environment, RHCs provide care to millions of rural residents, often serving as the sole health care provider in a community, and serving as the de facto safety net for rural residents.  The RHCs require support to effectively participate in the changing health care environment and need to be prepared for related policy and regulatory changes. This funding opportunity was announced on February 5, 2015. The application deadline is April 6, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

OASH: IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women

Funding Opportunity Number: WH-AST-15-001

The mission of the Office on Women's Health (OWH) is to provide national leadership and coordination to improve the health of women and girls through policy, education and innovative model programs. The Department of Health and Human Services has identified violence prevention as a major goal for improving health across several initiatives, including Healthy People. Further efforts are needed to ensure that all aspects of the health care system respond appropriately to women and girls who are victims of interpersonal violence. According to data from the CDC, women are disproportionately affected by intimate partner violence, sexual violence, and stalking; and victims experience many negative impacts and health consequences. Preliminary work supported by OWH highlighted the need for more collaborative violence prevention and health-related programs and projects. Previous work sponsored by OWH has illustrated the need to connect health care providers and public health programs to IPV programs. Strategies have included train-the-trainer methods, clear messaging, and development of services. OWH work also supports the importance of including geographically and ethnically diverse sites to maximize impact and social responsibility to underserved populations. Across all strategies and sites, the over-riding goal has been to develop the connection and support the linkage between systems that provide health care services and IPV programs for women. The next step is to test models that implement the linkages using robust methodologies to test interventions and evaluate programs. This funding opportunity was announced on February 6, 2015. The application deadline is May 12, 2015. For more information, please visit OASH's Full Funding Opportunity Announcement.

 

ONC: Workforce Training to Educate Health Care Professionals in Health Information Technology

Funding Opportunity Number: WF-WF-15-300

The purpose of this program is to provide assistance to institutions of higher education to establish or expand medical health informatics education programs to promote the rapid and effective utilization and development of health information technologies. This funding opportunity was announced on February 3, 2015. The application deadline is April 6, 2015. For more information, please visit ONC's Full Funding Opportunity Announcement.

 

ONC: Community Health Peer Learning Program

Funding Opportunity Number: CLP-CL-15-001

The purpose of this Funding Opportunity Announcement (FOA) is to address health challenges at the population level through a community-based collaborative approach. The Community Health Peer Learning Program supports HHS efforts to promote the development of a nationwide health information infrastructure built on the sustainable efforts of local providers and communities. This funding opportunity was announced on February 3, 2015. The application deadline is April 6, 2015. For more information, please visit ONC's Full Funding Opportunity Announcement.

 

PCORI:  Research Meeting and Conference Support

This Funding Opportunity Announcement (FOA) solicits meeting and conference support for patient-centered outcomes research/clinical comparative effectiveness research, including support for meetings and conferences that align with PCORI’s mission and strategic plan and facilitate expansion of patient-centered outcomes research/clinical comparative effectiveness research. The next application deadline is April 1, 2015. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

PCORI: Knowledge, Training and Development, and Dissemination Awards

This Funding Opportunity Announcement (FOA) solicits applications for the Eugene Washington PCORI Engagement Awards program. These awards support projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/clinical effectiveness research enterprise. A letter of intent is due by April 1, 2015. Applications will be accepted by invitation only. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

PCORI: Supporting Dissemination and Implementation Activities of the PCORI Pilot Projects Learning Network (PPPLN)

This Funding Opportunity Announcement (FOA) solicits applications to support the dissemination and implementation activities for the PCORI Pilot Projects and the PCORI Pilot Projects Learning Network. This FOA aligns with the PCORI strategic goal of disseminating information and encouraging adoption of PCORI-funded research results—as well as supporting best practices for engaging patients and other key community stakeholders in research dissemination and implementation. The application deadline April 16, 2015. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

PCORI: Clinical Management of Hepatitis C Infection

This Funding Opportunity Announcement (FOA) solicits applications to support pragmatic clinical trials (PCTs), or large-scale observational studies that compare two or more alternatives for addressing prevention, diagnosis, treatment, or management of hepatitis C infection. PCORI is interested in comparative studies that evaluate alternative strategies for planning, implementing and managing care for hepatitis C. The research is expected to examine treatment options as well as systems-level interventions or those aimed at eliminate health or healthcare disparities. Proposed studies must address clinical and healthcare delivery choices faced by patients, their caregivers, clinicians, and/or delivery systems. Proposed studies must compare two or more active interventions. They must involve patient populations that are representative of the U.S. population and be large enough to provide precise estimates of hypothesized effectiveness differences and to support evaluation of potential differences in treatment effectiveness in patient subgroups. A letter of intent is due by March 6, 2015. The application deadline is May 5, 2015. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

PCORI: Improving Methods for Conducting Patient-Centered Outcomes Research

This Funding Opportunity Announcement (FOA) seeks to address gaps in methodological research relevant to conducting patient-centered outcomes research (PCOR). Results of these projects will inform future iterations of PCORI’s Methodology Report. The improvement of existing methods will benefit all stakeholders, including researchers planning investigations, policy makers weighing the value of healthcare interventions, and patients, clinicians, and caregivers facing healthcare decisions. A letter of intent is due by March 6, 2015. The application deadline is May 5, 2015. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

PCORI: Addressing Disparities

This Funding Opportunity Announcement (FOA) solicits applications to support comparative effectiveness research (CER) studies that evaluate and compare new and/or enhanced interventions to reduce or eliminate disparities in health and healthcare. Studies in the Addressing Disparities program should focus on overcoming barriers that may disproportionately affect the outcomes of specific groups of patients, or identify best practices for sharing results and information about patient-centered research across patient groups. A letter of intent is due by March 6, 2015. The application deadline is May 5, 2015. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

PCORI: Communication and Dissemination Research

The purpose of this Funding Opportunity Announcement (FOA) is to address critical knowledge gaps in the communication and dissemination process—both the communication and dissemination of research results to patients, their caregivers, and clinicians, as well as the communication between patients, caregivers, and clinicians in the service of enabling patients and caregivers to make the best possible decisions in choosing among available options for care and treatment. A letter of intent is due by March 6, 2015. The application deadline is May 5, 2015. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

PCORI: Assessment of Prevention, Diagnosis, and Treatment Options

This Funding Opportunity Announcement (FOA) solicits applications to support comparative effectiveness research designed to provide information that would inform critical decisions that face patients and caregivers, clinicians, policy makers, and healthcare system leaders. These decisions must be consequential and be occurring now in the absence of sound evidence about the comparative effectiveness of alternative approaches. There must be substantial potential that patients/caregivers will benefit from the new knowledge in ways that are important to them. The premise of this research is that the new knowledge will inform critical choices by patients and stakeholders in health care. This knowledge will provide insight about the comparative benefits and harms of the options and provide information about outcomes that are important to patients. A letter of intent is due by March 6, 2015. The application deadline is May 5, 2015. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

PCORI: Improving Healthcare Systems

This Funding Opportunity Announcement (FOA) solicits applications to study the comparative effectiveness of alternate features of healthcare systems, including innovative technologies, incentive structures, service designs, all intended to optimize the quality, outcomes, and/or efficiency of care for the patients they serve and that have the most potential for sustained impact and replication within and across healthcare systems. Healthcare systems encompass multiple levels and include entities organized to deliver, arrange, purchase, and/or coordinate healthcare services. PCORI seeks to fund studies that will provide information of value to patients, their caregivers, clinicians, and healthcare leaders regarding which features of delivery systems lead to better patient-centered outcomes so they may ultimately impact healthcare delivery. A letter of intent is due by March 6, 2015. The application deadline is May 5, 2015. For more information, please visit PCORI's Full Funding Opportunity Announcement.

 

 

NIH Funding Opportunity Announcements:

 

NIH: Developing Technologies and Tools to Monitor HIV Brain Reservoirs and How They May be Altered by Exposure to Substances of Abuse

Funding Opportunity Number: RFA-DA-15-018

The purpose of this Funding Opportunity Announcement (FOA) is to support projects developing technologies and tools to detect and quantify HIV brain reservoirs and how they may be altered by exposure to substances of abuse. The ability to monitor and quantify latent HIV in living human brains is one of the ultimate goals of supporting this work. It is, therefore, necessary to either improve our ability to detect and quantify HIV latent reservoirs in the living human brain, and/or examine potential biomarkers of latent infection in the brain to determine if substances of abuse modulate the characteristics of the reservoirs.  This initiative should help to establish important groundwork for the detection and eradication of HIV brain reservoirs in substance-abusing populations. This funding opportunity was announced on February 3, 2015. The application deadline is April 10, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

 

NIH: BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System

Funding Opportunity Number: RFA-NS-15-008

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue a small clinical study to obtain critical information necessary to advance recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain. Clinical studies may consist of acute or short-term procedures that are deemed Non-Significant Risk (NSR) by an Institutional Review Board, or Significant Risk (SR) studies that require an Investigational Device Exemption (IDE) from the FDA, such as chronic implants. The clinical study should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical study is expected to provide information that cannot be practically obtained through additional nonclinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This funding opportunity was announced on February 3, 2015. The application deadline is April 14, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Adolescent Brain Cognitive Development (ABCD) Study - Data Analysis and Informatics Center

Funding Opportunity Number: RFA-DA-15-016

The objective of the Adolescent Brain Cognitive Development (ABCD) Study Consortium is to establish a national, multisite, longitudinal cohort study to prospectively examine the neurodevelopmental and behavioral effects of substance use from early adolescence (approximately age 9-10) through the period of risk for substance use and substance use disorders. The structure of the Consortium shall consist of three highly integrated components that may be linked at the time of submission: (1) a set of Research Project Sites, (2) a single central Data Analysis and Informatics Center, and (3) a single overall Coordinating Center. Unlinked applications will also be accepted, and if selected for funding, will be linked to other applications to form a Consortium after review. This Funding Opportunity Announcement (FOA) solicits applications for a single central Data Analysis and Informatics Center. This FOA parallels companion FOAs that solicit applications for Research Project Sites (RFA-DA-15-015) and a single overall Coordinating Center (RFA-DA-15-014). It is expected that investigators upon funding will work jointly with NIH scientific staff to assist, guide, coordinate, or participate in project activities. This funding opportunity was announced on February 4, 2015. A letter of intent is due by March 14, 2015. The application deadline is April 14, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Adolescent Brain Cognitive Development (ABCD) Study - Research Project Sites

Funding Opportunity Number: RFA-DA-15-015

The objective of the Adolescent Brain Cognitive Development (ABCD) Study Consortium is to establish a national, multisite, longitudinal cohort study to prospectively examine the neurodevelopmental and behavioral effects of substance use from early adolescence (approximately age 9-10) through the period of risk for substance use and substance use disorders. The structure of the Consortium shall consist of three highly integrated components that may be linked at the time of submission: (1) a set of Research Project Sites, (2) a single central Data Analysis and Informatics Center, and (3) a single overall Coordinating Center. Unlinked applications will also be accepted, and if selected for funding, will be linked to other applications to form a Consortium after review. This Funding Opportunity Announcement (FOA) solicits applications for Research Project Sites. This FOA runs in parallel with companion FOAs that solicit applications for a single Coordinating Center (RFA-DA-15-014) and a single central Data Analysis and Informatics Center (RFA-DA-15-016). It is expected that investigators, upon funding, will work jointly with NIH scientific staff to assist, guide, coordinate, or participate in project activities. This funding opportunity was announced on February 4, 2015. A letter of intent is due by March 14, 2015. The application deadline is April 14, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

 

 

NIH: Adolescent Brain Cognitive Development (ABCD) Study - Coordinating Center

Funding Opportunity Number: RFA-DA-15-014

The objective of the Adolescent Brain Cognitive Development (ABCD) Study Consortium is to establish a national, multisite, longitudinal cohort study to prospectively examine the neurodevelopmental and behavioral effects of substance use from early adolescence (approximately age 9-10) through the period of risk for substance use and substance use disorders. The structure of the Consortium shall consist of three highly integrated components that may be linked at the time of submission: (1) a set of Research Project Sites, (2) a single central Data Analysis and Informatics Center, and (3) a single overall Coordinating Center. Unlinked applications will also be accepted, and if selected for funding, will be linked to other applications to form a Consortium after review. This Funding Opportunity Announcement (FOA) solicits applications for a single overall Coordinating Center. This FOA runs in parallel with companion FOAs that solicit applications for Research Projects Sites (RFA-DA-15-015) and a single central Data Analysis and Informatics Center (RFA-DA-15-016). It is expected that investigators upon funding will work jointly with NIH scientific staff to assist, guide, coordinate, or participate in project activities. This funding opportunity was announced on February 4, 2015. A letter of intent is due by March 14, 2015. The application deadline is April 14, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Gene-Environment Interplay in Substance Use Disorders

Funding Opportunity Numbers: PA-15-110, PA-15-111, and PA-15-112

This Funding Opportunity Announcement (FOA) seeks to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates. Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field. Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and cessation of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies. These funding opportunities were announced on February 4, 2015. The initial application deadline for PA-15-110 is June 5, 2015. The initial application deadline for PA-15-111 and PA-15-112 is June 16, 2015. For more information, please visit NIH's Full Funding Opportunity Announcements for PA-15-110, PA-15-111, and PA-15-112.

 

NIH: Phased Innovation Award for Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics

Funding Opportunity Number: RFA-AT-16-001

The goal of this Funding Opportunity Announcement (FOA) is to support pilot testing of natural products (i.e., botanicals, dietary supplements, and probiotics), which have sufficient early-stage data to justify further clinical testing of the product. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. The data collected should be used to fill gaps in scientific knowledge and provide the information necessary to develop a competitive full-scale clinical trial. Support will be provided for an initial phase of up to two years for milestone-driven bioavailability and pharmacokinetic testing and assessment of the natural products biological signature or mechanism of action. Based on the results, the initial phase may be followed by support of a second phase of up to 3 years support for further clinical studies of the natural product. This FOA is not appropriate for support of randomized clinical trials to test or determine efficacy. Ultimately, this FOA is intended to speed the translation of emerging basic science findings about natural products into clinical pilot testing to determine whether continued clinical research is warranted. This funding opportunity was announced on February 6, 2015. The initial application deadline is June 22, 2015. A letter of intent is due 30 days prior to the corresponding application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics

Funding Opportunity Number: RFA-AT-16-002

The goal of this Funding Opportunity Announcement (FOA) is to support pilot testing of natural products (i.e., botanicals, dietary supplements, and probiotics), which have sufficient early-stage data to justify further clinical testing of the product. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. The data collected should be used to fill gaps in scientific knowledge and provide the information necessary to develop a competitive full-scale clinical trial. Support will be provided to confirm the link between the impact of natural products on the biological signature (i.e., mechanism of action) and demonstrate an association between the change in the biological signature and clinical outcomes. Ultimately, this FOA is intended to speed the translation of emerging basic science findings about natural products into clinical pilot testing to determine whether continued clinical research is warranted. This funding opportunity was announced on February 6, 2015. The initial application deadline is June 29, 2015. A letter of intent is due 30 days prior to the corresponding application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases

Funding Opportunity Number: PAR-15-115

This Funding Opportunity Announcement (FOA) seeks to encourage Research Project Grant applications to pursue clinical observational (CO) studies to obtain data necessary for designing clinical trials for musculoskeletal, rheumatic, or skin diseases or conditions. Research data from observational cohort studies can enhance clinical trial design by providing essential information about disease symptoms, stages and timing of disease progression, comorbid conditions, availability of potential clinical trial participants, and outcomes that are important to patients. CO studies also can facilitate efforts to develop and/or validate objective biomarkers or subjective outcome measures for use in a future trial or trials. Applicants to this FOA are encouraged to propose studies that address significant obstacles or questions in the design of a clinical trial, such as determining the appropriate primary or secondary outcome measures, or identifying the stages of disease during which patients are most likely to respond to an intervention. Only observational studies will be supported through this FOA. This funding opportunity was announced on February 6, 2015. The initial application deadline is July 1, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Lifespan Human Connectome Project: Aging

Funding Opportunity Number: RFA-AG-16-004

This Funding Opportunity Announcement (FOA) is issued as an initiative of the NIH Blueprint for Neuroscience Research. The Neuroscience Blueprint is a collaborative framework through which 15 NIH Institutes, Centers, and Offices jointly support neuroscience-related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders. The Neuroscience Blueprint is supporting a Lifespan Human Connectome Project (L-HCP) to extend the Human Connectome Project (HCP) to map connectivity in the developing, adult, and aging human brain. The goal of this FOA is to solicit grant applications that propose to extend the experimental protocols developed through the HCP to middle-age and elderly adults to investigate the structural and functional changes that occur in the brain during typical aging. A companion FOA is soliciting applications that apply the HCP protocols to children and adolescents to explore changes that occur during typical development. This funding opportunity was announced on February 6, 2015. A letter of intent is due by May 15, 2015. The application deadline is June 15, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Lifespan Human Connectome Project: Development 

Funding Opportunity Number: RFA-MH-16-150

This Funding Opportunity Announcement (FOA) is issued as an initiative of the NIH Blueprint for Neuroscience Research. The Neuroscience Blueprint is a collaborative framework through which 15 NIH Institutes, Centers, and Offices jointly support neuroscience-related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders. The Neuroscience Blueprint is supporting a Lifespan Human Connectome Project (L-HCP) to extend the Human Connectome Project (HCP) to map connectivity in the developing, adult, and aging human brain. The goal of this FOA is to solicit grant applications that propose to extend the experimental protocols developed through the HCP to children and adolescents to investigate the structural and functional changes that occur in the brain during typical development.A companion FOA is soliciting applications that apply the HCP protocols to middle age and elderly adults to explore changes that occur during normal aging. This funding opportunity was announced on February 6, 2015. A letter of intent is due by May 15, 2015. The application deadline is June 15, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center 

Funding Opportunity Numbers: RFA-DK-15-503 and RFA-DK-15-505

These Limited Competition Funding Opportunity Announcements (FOAs) continue follow-up of the Diabetes Prevention Program Outcomes Study (DPPOS) cohort. The Diabetes Prevention Program (DPP) was a multi-center controlled clinical trial examining the efficacy of treatments to prevent or delay the development of type 2 diabetes in a population at high risk. The DPP demonstrated that either lifestyle change or the drug metformin could reduce the development of type 2 diabetes by 58% and 31%, respectively, compared with placebo. Following the end of DPP, the DPP cohort was enrolled in the DPPOS to determine the long-term effects of the DPP interventions on further diabetes development and microvascular complications. The primary purpose of these FOAs is to support the DPPOS Biostatistics Research Center to continue follow-up of the DPPOS cohort to examine the effectiveness of early metformin treatment on the development of cardiovascular disease and cancer. These funding opportunities were announced on February 6, 2015. A letter of intent for each opportunity is due by March 9, 2015. The application deadline for both opportunities is April 9, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.


Association Management Software Powered by YourMembership  ::  Legal